The first iteration of the Advanced Prostate Cancer Consensus Conference (APCCC) was held in St. Gallen, Switzerland, in 2017, and the second iteration is upcoming in late August this year — this time in Basel. … READ MORE …
Filed under: Management, Treatment | Tagged: advanced, APCCC, consensus, controversy, resolution | 1 Comment »
A new article in JAMA Internal Medicine this week is likely to keep the fires burning under the PSA screening controversy for quite a while to come. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: controversy, Diagnosis, risk, screening, testing | 4 Comments »
Long-time prostate cancer advocates (and of course all members of the clinical treatment community) are well aware of the controversies that complicate testing for, diagnosing, and managing prostate cancer. However, for men approaching their mid 40s and early 50s and newly diagnosed patients this can come as a major shock. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: controversy, decision-making | 16 Comments »
The whole issue of the appropriateness of cancer screening is starting to become a major public health issue, closely and inevitably associated with cancer risk. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk | Tagged: controversy, Prevention, risk, screening | 4 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 